SONARA HEALTH INC
Software platform for opioid use disorder patient engagement and methadone treatment adherence
- Sector
- Digital health
- Headquarters
- DALLAS, TX
- Founded
- 2020
- Latest Form D
- $4.4M, Mar 2025
- Total capital
- $11.2M
- Federal grants
- $2.7M
- 5 awards · 2022–2026
- Sector median 0 awards
- Private capital raised
- $8.5M
- 4 Form D · last Mar 2025
- 19 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 4 pending · first 2022
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care$705K
- Private capital raisedForm D · SEC · 4th filing$4.4M
- Federal grantHealth and Human S · Phase II · Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care$865K
- Federal grantHealth and Human S · Phase II · Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care$812K
- Federal grantHealth and Human S · Phase I · Remotely Observed Methadone Evaluation (ROME)$55K
- Private capital raisedForm D · SEC · 3rd filing$2.3M
- Private capital raisedForm D · SEC · 2nd filing$550K
- Private capital raisedForm D · SEC · 1st filing$1.3M
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Remotely Observed Methadone Evaluation (ROME)$268K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
1month
from SONARA HEALTH INC’s first federal award to its first private round.
- First federal award · Aug 2022
- Health and Human S · $268K
- First Form D · Sep 2022
- $1.3M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Founders and team
Researcher links verified by same-company patents and grants- MICHAEL GILESResearcherExecutive Officer, DirectorLinked by 2 patents · $2.7M in grants as PI
- DANIEL R. KARLINDirectorNamed in SEC Form D filings
- JUSTIN R. GELLERExecutive OfficerNamed in SEC Form D filings
- RACHEL KERNDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 6- PendingSystem Incentivizing And Adjusting Drug DeliveryUSPTOApplication 18998867
- GrantedSystem and Method for Monitoring Drug DeliveryUSPTOUS 11,783,932
- GrantedSystem and Method for Monitoring Drug DeliveryUSPTOUS 11,521,726
Show all 6 patent records
- System Incentivizing And Adjusting Drug DeliveryFeb 26, 2026 · Application 18998867Pending
- System and Method for Monitoring Drug DeliveryOct 10, 2023 · US 11,783,932Granted
- System and Method for Monitoring Drug DeliveryDec 6, 2022 · US 11,521,726Granted
- Pill Packet System And Method Of UseApplication 63369320Pending
- System Incentivizing And Adjusting Drug DeliveryApplication PCTUS2023070674Pending
- System And Method For Monitoring Drug DeliveryApplication PCTUS2022070291Pending
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .